Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Jul 24, 2020 at 11:25 AM EDT

Moderna’s Pain Is Arbutus’s Gain in COVID-19 Patent Ruling

Arbutus Biopharma stock has seen an incredible rise over the past few days after the firm won a patent dispute…

Chris Lange | Jul 24, 2020 at 10:51 AM EDT

Goldman Sachs Sees Big Gains From 7 Biotech & Pharma Conviction Buy Stocks

Goldman Sachs has seven biopharma stocks on its Conviction Buy list, and these are not all coronavirus plays. The firm…

Chris Lange | Jul 22, 2020 at 10:04 AM EDT

Pfizer and BioNTech Set to Receive a Sweet Payoff for COVID-19 Vaccines

Pfizer and BioNTech S.E. aim to begin delivering 300 million doses of their vaccine for COVID-19 in 2021, but in…

Paul Ausick | Jul 22, 2020 at 8:37 AM EDT

7 Post-Coronavirus Health Care Stocks That Will Win in the Years Ahead

The current focus on controlling the COVID-19 pandemic, companies that provide other health care products and services have received less…

Jon C. Ogg | Jul 21, 2020 at 12:10 PM EDT

Owens & Minor Just Set Its Future Way Beyond COVID-19

There are no assurances that this stock will keep rising after such a rapid rise, but many investors with a…

Chris Lange | Jul 21, 2020 at 11:23 AM EDT

BioNTech Raises Over $400 Million to Boost COVID-19 Efforts

BioNTech is one of the leading companies in the race to a COVID-19 vaccine. With its shares up more than…

Chris Lange | Jul 21, 2020 at 10:56 AM EDT

Late-Stage Diabetes Study Sets the Stage for Lexicon Pharma

Lexicon Pharmaceuticals shares surged on Tuesday after the company announced positive topline data for its late-stage studies in type 2…

Chris Lange | Jul 21, 2020 at 10:09 AM EDT

Moleculin Biotech’s Antimetabolites COVID-19 on Track for Treatment Status

Moleculin Biotech joins the ever-expanding list of coronavirus stocks as the company announced that a second round of independent laboratory…

Chris Lange | Jul 21, 2020 at 8:51 AM EDT

Why Immuron’s New COVID-19 Study Is a Game Changer

Immuron continued its winning streak on Tuesday after the company announced that its IMM-124E has demonstrated neutralizing activity against the…

Douglas A. McIntyre | Jul 21, 2020 at 6:15 AM EDT

Peru and Chile Take Brunt of COVID-19 Spread

While the United States considers its COVID-19 spread with horror, two much smaller nations have suffered tremendously as well.

Chris Lange | Jul 20, 2020 at 2:51 PM EDT

Why This FDA Clearance Is a Big Deal For Sorrento Therapeutics

Sorrento Therapeutics has announced that its treatment for COVID-19 had cleared its Phase 2 study in hospitalized patients with moderate…

Chris Lange | Jul 20, 2020 at 10:21 AM EDT

GlaxoSmithKline Joins the Race for a COVID-19 Vaccine

GlaxoSmithKline has announced that it is acquiring a 10% stake in the German biopharma firm CureVac.

Chris Lange | Jul 20, 2020 at 9:52 AM EDT

Pfizer and BioNTech Make Another Big Step for COVID-19 Vaccine

BioNTech and Pfizer are leading the pack of COVID-19 vaccine stocks as this collaboration came out with more positive news…

Douglas A. McIntyre | Jul 20, 2020 at 6:37 AM EDT

3 Countries Have Over a Million COVID-19 Cases

As the COVID-19 pandemic continues around the world, and the number of cases in the United States rises relentlessly, there…

Lee Jackson | Jul 18, 2020 at 6:55 AM EDT

Goldman Sachs Has 4 Red-Hot Biotech Stocks to Buy Under $10

These four sizzling biotech stocks trading under the $10 level have big upside to the analysts' price targets. All of…

1 … 47 48 49 50 51 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Moderna’s Pain Is Arbutus’s Gain in COVID-19 Patent Ruling

Goldman Sachs Sees Big Gains From 7 Biotech & Pharma Conviction Buy Stocks

Pfizer and BioNTech Set to Receive a Sweet Payoff for COVID-19 Vaccines

7 Post-Coronavirus Health Care Stocks That Will Win in the Years Ahead

Owens & Minor Just Set Its Future Way Beyond COVID-19

BioNTech Raises Over $400 Million to Boost COVID-19 Efforts

Late-Stage Diabetes Study Sets the Stage for Lexicon Pharma

Moleculin Biotech’s Antimetabolites COVID-19 on Track for Treatment Status

Why Immuron’s New COVID-19 Study Is a Game Changer

Peru and Chile Take Brunt of COVID-19 Spread

Why This FDA Clearance Is a Big Deal For Sorrento Therapeutics

GlaxoSmithKline Joins the Race for a COVID-19 Vaccine

Pfizer and BioNTech Make Another Big Step for COVID-19 Vaccine

3 Countries Have Over a Million COVID-19 Cases

Goldman Sachs Has 4 Red-Hot Biotech Stocks to Buy Under $10

7 Reasons Why Wall Street May Regret Trump Nominating Kevin Warsh for Fed Chair

This Overlooked Precious Metals ETF Offers a 7% Yield

Why Gold Won’t Save You in a Real Crisis (But Stocks Will)

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

7 Reasons Why Wall Street May Regret Trump Nominating Kevin Warsh for Fed Chair

This Overlooked Precious Metals ETF Offers a 7% Yield

Health and Healthcare Articles

All Health and Healthcare Articles

Moderna’s Pain Is Arbutus’s Gain in COVID-19 Patent Ruling

Goldman Sachs Sees Big Gains From 7 Biotech & Pharma Conviction Buy Stocks

Pfizer and BioNTech Set to Receive a Sweet Payoff for COVID-19 Vaccines

7 Post-Coronavirus Health Care Stocks That Will Win in the Years Ahead

Owens & Minor Just Set Its Future Way Beyond COVID-19

BioNTech Raises Over $400 Million to Boost COVID-19 Efforts

Late-Stage Diabetes Study Sets the Stage for Lexicon Pharma

Moleculin Biotech’s Antimetabolites COVID-19 on Track for Treatment Status

Why Immuron’s New COVID-19 Study Is a Game Changer

Peru and Chile Take Brunt of COVID-19 Spread

Why This FDA Clearance Is a Big Deal For Sorrento Therapeutics

GlaxoSmithKline Joins the Race for a COVID-19 Vaccine

Pfizer and BioNTech Make Another Big Step for COVID-19 Vaccine

3 Countries Have Over a Million COVID-19 Cases

Goldman Sachs Has 4 Red-Hot Biotech Stocks to Buy Under $10

7 Reasons Why Wall Street May Regret Trump Nominating Kevin Warsh for Fed Chair

This Overlooked Precious Metals ETF Offers a 7% Yield

Why Gold Won’t Save You in a Real Crisis (But Stocks Will)

Featured Reads

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up